BIOPHARMX CORPORATION SUBSCRIPTION AGREEMENTSubscription Agreement • May 2nd, 2016 • BioPharmX Corp • Pharmaceutical preparations • New York
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 2nd, 2016 • BioPharmX Corp • Pharmaceutical preparations • New York
THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of October 24, 2014, by and among (i) (a) BioPharmX Corporation, a Delaware corporation (the “Company”), (b) James Pekarsky (“Pekarsky”), Anja Krammer (“Krammer”) and Kin Chan (“Chan”)(together the “Senior Management”) and (ii) the subscribers for the Company’s Series A Preferred Stock which are parties to the Subscription Agreement (as defined below)(the “Subscribers”). Capitalized terms used herein but not otherwise defined herein shall have the respective meanings set forth in the Subscription Agreement (as defined below).
